ArticleCureus2025
Uncovering Glucose-6-Phosphate Isomerase (GPI) Deficiency in a Five-Year-Old With Hemolytic Anemia in Bahrain.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glucose-6-phosphate isomerase (GPI) deficiency is a rare autosomal recessive enzymopathy that presents with chronic nonspherocytic hemolytic anemia. We report the case of a five-year-old Bahraini girl with a history of neonatal jaundice and recurrent episodes of anemia. A comprehensive diagnostic workup, including peripheral smear, bone marrow examination, and whole-exome sequencing, revealed a homozygous likely pathogenic variant in the GPI gene, confirming the diagnosis of GPI deficiency. The patient was managed with supportive measures including blood transfusions, folic acid, vitamin D supplementation, and iron chelation therapy. This case underscores the importance of considering rare inherited enzymatic disorders in the differential diagnosis of pediatric hemolytic anemia and highlights the critical role of genetic testing in achieving diagnostic clarity and informing long-term care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.